Literature DB >> 8628237

Suppression of the Bgl+ phenotype of a delta hns strain of Escherichia coli by a Bacillus subtilis antiterminator binding site.

C Beloin1, L Hirschbein, F Le Hégarat.   

Abstract

Bacillus subtilis, like Escherichia coli, possesses several sets of genes involved in the utilization of beta-glucosides. In E. coli, all these genes are cryptic, including the genes forming the bgl operon, thus leading to a Bgl- phenotype. We screened for B. subtilis chromosomal DNA fragments capable of reverting the Bgl+ phenotype associated with an E. coli hns mutant to the Bgl- wild-type phenotype. One B. subtilis chromosomal fragment having this property was selected. It contained a putative Ribonucleic AntiTerminator binding site (RAT sequence) upstream from the bgl gene. Deletion studies as well as subcloning experiments allowed us to prove that the putative B. subtilis of the E. coli bgl operon. We propose that this repression results from the titration of the BglG antiterminator protein of E. coli bgl operon by our putative B. subtilis bglP RAT sequence. Thus, we report evidence for a new cross interaction between heterologous RAT-antiterminator protein pairs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8628237     DOI: 10.1007/bf02172988

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  27 in total

1.  Induction of levansucrase in Bacillus subtilis: an antitermination mechanism negatively controlled by the phosphotransferase system.

Authors:  A M Crutz; M Steinmetz; S Aymerich; R Richter; D Le Coq
Journal:  J Bacteriol       Date:  1990-02       Impact factor: 3.490

2.  Transcriptional antitermination in the bgl operon of E. coli is modulated by a specific RNA binding protein.

Authors:  F Houman; M R Diaz-Torres; A Wright
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

3.  Complete physical map of the Bacillus subtilis 168 chromosome constructed by a gene-directed mutagenesis method.

Authors:  M Itaya; T Tanaka
Journal:  J Mol Biol       Date:  1991-08-05       Impact factor: 5.469

4.  The chromatin-associated protein H-NS.

Authors:  D W Ussery; J C Hinton; B J Jordi; P E Granum; A Seirafi; R J Stephen; A E Tupper; G Berridge; J M Sidebotham; C F Higgins
Journal:  Biochimie       Date:  1994       Impact factor: 4.079

5.  Protein phosphorylation regulates transcription of the beta-glucoside utilization operon in E. coli.

Authors:  O Amster-Choder; F Houman; A Wright
Journal:  Cell       Date:  1989-09-08       Impact factor: 41.582

6.  The sacT gene regulating the sacPA operon in Bacillus subtilis shares strong homology with transcriptional antiterminators.

Authors:  M Debarbouille; M Arnaud; A Fouet; A Klier; G Rapoport
Journal:  J Bacteriol       Date:  1990-07       Impact factor: 3.490

7.  BglR protein, which belongs to the BglG family of transcriptional antiterminators, is involved in beta-glucoside utilization in Lactococcus lactis.

Authors:  J Bardowski; S D Ehrlich; A Chopin
Journal:  J Bacteriol       Date:  1994-09       Impact factor: 3.490

8.  The DNA sequence of the gene for the secreted Bacillus subtilis enzyme levansucrase and its genetic control sites.

Authors:  M Steinmetz; D Le Coq; S Aymerich; G Gonzy-Tréboul; P Gay
Journal:  Mol Gen Genet       Date:  1985

9.  Inducible system for the utilization of beta-glucosides in Escherichia coli. I. Active transport and utilization of beta-glucosides.

Authors:  S Schaefler
Journal:  J Bacteriol       Date:  1967-01       Impact factor: 3.490

10.  New beta-glucoside (bgl) genes in Bacillus subtilis: the bglP gene product has both transport and regulatory functions similar to those of BglF, its Escherichia coli homolog.

Authors:  D Le Coq; C Lindner; S Krüger; M Steinmetz; J Stülke
Journal:  J Bacteriol       Date:  1995-03       Impact factor: 3.490

View more
  1 in total

1.  Expression of the bglH gene of Lactobacillus plantarum is controlled by carbon catabolite repression.

Authors:  R Marasco; L Muscariello; M Varcamonti; M De Felice; M Sacco
Journal:  J Bacteriol       Date:  1998-07       Impact factor: 3.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.